Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 17, Number 12—December 2011

Seroprevalence of Alkhurma and Other Hemorrhagic Fever Viruses, Saudi Arabia

Ziad A. MemishComments to Author , Ali Albarrak, Mohammad A. Almazroa, Ibrahim Al-Omar, Rafat Alhakeem, Abdullah M. Assiri, Shamsudeen Fagbo, Adam MacNeil, Pierre E. Rollin, Nageeb Abdullah, and Gwen Stephens
Author affiliations: Ministry of Health, Riyadh, Kingdom of Saudi Arabia (Z.A. Memish, M.A. Almazroa, I. Al-Omar, R. Alhakeem, A. Assiri, S. Fagbo, N. Abdullah, G. Stephens); Riyadh Military Hospital, Riyadh (A. Albarrak); Centers for Disease Control and Prevention, Atlanta, Georgia, USA (A. MacNeil, P.E. Rollin); University of British Columbia, Vancouver, British Columbia, Canada (G. Stephens)

Main Article


Serologic status of 1,024 soldiers evaluated for IgG and IgM ELISA reactivity against AHFV, CCHF, DENV, and RVFV antigens, Saudi Arabia, 2009*

Virus No. (%) IgG reactive No. IgM reactive No. symptomatic Seroprevalence/100 soldiers tested
RVFV 20 (2.0) 1 1 (rash) 1.95
AHFV 13 (1.3) 0 0 1.27
CCHF 6 (0.6) 0 0 0.58
DENV 1 (0.1) 0 0 0.1
Total 40 (3.9) 1 1 3.9

*AHFV, Alkhurma hemorrhagic fever virus; CCHF, Crimean-Congo hemorrhagic fever; DENV, dengue virus; RVFV, Rift Valley fever virus.

Main Article

Page created: November 22, 2011
Page updated: November 22, 2011
Page reviewed: November 22, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.